Inhibitors of cyclin dependent kinases
US5733920A · kind A · utility
53Cited by
3References
37Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 31, 1995 |
| Grant date | Mar 31, 1998 |
| Priority date | — |
| Expiry date | Oct 31, 2015 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention provides novel inhibitors of cyclin-dependent kinases, in particular inhibitors of the CDK/cyclin complexes such as CDK4/cyclin D1. The novel compounds are analogs of chromones. These compounds can be used for inhibiting excessive or abnormal cell proliferation. Thus, the novel compounds are useful for treating a subject with a disorder associated with excessive cell proliferation, such as cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.